UK markets open in 1 hour 16 minutes
NIKKEI 225
38,763.58 +273.41 (+0.71%) HANG SENG
18,476.74 +51.78 (+0.28%) CRUDE OIL
74.46 +0.39 (+0.53%) GOLD FUTURES
2,387.90 +12.40 (+0.52%) DOW
38,807.33 +96.04 (+0.25%) Bitcoin GBP
55,429.79 -41.88 (-0.08%)
BMY Sep 2024 46.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:56AM EDT. Market open.
| Previous close | 0.7400 |
| Open | 0.7900 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 46.00 |
| Expiry date | 2024-09-20 |
| Day's range | 0.7400 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Insider MonkeyHere’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
We recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE:BMY) ranks 2nd in the list. Click to see the full list of 11 stocks Cramer is bearish on. In this article we will take a deeper look at BMY and find out whether Cramer’s thesis holds any weight. […]
ZacksBristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
- Zacks
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
© 2024 Yahoo. All rights reserved.